Andrea Christoforou, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nootropic Agents | 3 | 2021 | 160 | 0.470 |
Why?
|
| Postural Balance | 1 | 2017 | 621 | 0.420 |
Why?
|
| Cognition | 12 | 2021 | 6759 | 0.390 |
Why?
|
| Genome-Wide Association Study | 18 | 2021 | 12259 | 0.380 |
Why?
|
| Exercise Therapy | 1 | 2017 | 904 | 0.360 |
Why?
|
| Polymorphism, Single Nucleotide | 18 | 2019 | 15518 | 0.340 |
Why?
|
| Accidental Falls | 1 | 2017 | 1062 | 0.340 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 3608 | 0.330 |
Why?
|
| Linkage Disequilibrium | 1 | 2012 | 1996 | 0.290 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 7908 | 0.250 |
Why?
|
| Schizophrenia | 9 | 2021 | 6865 | 0.230 |
Why?
|
| Bipolar Disorder | 8 | 2016 | 5027 | 0.200 |
Why?
|
| Recovery of Function | 2 | 2019 | 2922 | 0.170 |
Why?
|
| Cognition Disorders | 3 | 2019 | 4041 | 0.150 |
Why?
|
| Persistent Vegetative State | 1 | 2019 | 260 | 0.150 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2014 | 957 | 0.150 |
Why?
|
| Coma | 1 | 2019 | 475 | 0.130 |
Why?
|
| Quality of Life | 1 | 2017 | 12788 | 0.130 |
Why?
|
| Intelligence | 2 | 2018 | 920 | 0.130 |
Why?
|
| Consciousness Disorders | 1 | 2019 | 418 | 0.130 |
Why?
|
| Consciousness | 1 | 2019 | 571 | 0.120 |
Why?
|
| Synaptic Transmission | 1 | 2019 | 1176 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2019 | 17439 | 0.110 |
Why?
|
| Independent Living | 1 | 2017 | 569 | 0.110 |
Why?
|
| Evidence-Based Practice | 1 | 2017 | 500 | 0.110 |
Why?
|
| Software | 2 | 2020 | 4440 | 0.110 |
Why?
|
| Gait | 1 | 2017 | 795 | 0.100 |
Why?
|
| Genetic Association Studies | 3 | 2016 | 2703 | 0.100 |
Why?
|
| Genetics, Behavioral | 1 | 2011 | 53 | 0.100 |
Why?
|
| Psychometrics | 1 | 2020 | 3000 | 0.100 |
Why?
|
| Educational Status | 1 | 2019 | 2540 | 0.100 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 505 | 0.100 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 1195 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2012 | 462 | 0.090 |
Why?
|
| Neuregulin-1 | 1 | 2010 | 142 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 1060 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2017 | 2483 | 0.080 |
Why?
|
| Haplotypes | 3 | 2016 | 2779 | 0.080 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2007 | 50 | 0.080 |
Why?
|
| Scotland | 3 | 2016 | 155 | 0.080 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2004 | 852 | 0.080 |
Why?
|
| Norway | 3 | 2014 | 448 | 0.080 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 437 | 0.070 |
Why?
|
| Genetic Loci | 4 | 2018 | 2575 | 0.070 |
Why?
|
| Genes, Homeobox | 2 | 2004 | 286 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2006 | 374 | 0.070 |
Why?
|
| Mental Disorders | 2 | 2018 | 6593 | 0.070 |
Why?
|
| Brain | 5 | 2018 | 26345 | 0.070 |
Why?
|
| Anophthalmos | 1 | 2004 | 22 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 3 | 2015 | 1340 | 0.060 |
Why?
|
| Coloboma | 1 | 2004 | 54 | 0.060 |
Why?
|
| Microphthalmos | 1 | 2004 | 54 | 0.060 |
Why?
|
| SUMO-1 Protein | 1 | 2004 | 35 | 0.060 |
Why?
|
| Family Health | 1 | 2009 | 1280 | 0.060 |
Why?
|
| Humans | 30 | 2021 | 743811 | 0.060 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2004 | 195 | 0.060 |
Why?
|
| Genotype | 6 | 2016 | 12944 | 0.060 |
Why?
|
| Prognosis | 2 | 2020 | 29052 | 0.060 |
Why?
|
| Repressor Proteins | 2 | 2004 | 3024 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 2715 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2016 | 4286 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2914 | 0.050 |
Why?
|
| Eye Proteins | 1 | 2004 | 645 | 0.050 |
Why?
|
| Male | 17 | 2019 | 349776 | 0.050 |
Why?
|
| Aged | 10 | 2019 | 163178 | 0.050 |
Why?
|
| Female | 18 | 2019 | 380020 | 0.050 |
Why?
|
| Pursuit, Smooth | 1 | 2019 | 41 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 57744 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2016 | 7880 | 0.040 |
Why?
|
| Hippocampus | 1 | 2012 | 3672 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 4463 | 0.040 |
Why?
|
| Genome, Human | 1 | 2012 | 4418 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2014 | 6622 | 0.040 |
Why?
|
| Neuropsychological Tests | 3 | 2016 | 6976 | 0.040 |
Why?
|
| Adult | 13 | 2019 | 213889 | 0.040 |
Why?
|
| Cefotaxime | 1 | 2017 | 35 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 4635 | 0.040 |
Why?
|
| Glasgow Coma Scale | 1 | 2019 | 570 | 0.040 |
Why?
|
| Middle Aged | 11 | 2019 | 213241 | 0.040 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2012 | 3655 | 0.040 |
Why?
|
| Aging | 2 | 2012 | 8655 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2004 | 1986 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2006 | 2614 | 0.030 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2016 | 100 | 0.030 |
Why?
|
| Alleles | 1 | 2006 | 6934 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2019 | 77410 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2004 | 2419 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2004 | 1900 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2004 | 2969 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2004 | 2927 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2016 | 2305 | 0.030 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2016 | 266 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2016 | 437 | 0.030 |
Why?
|
| Twins | 1 | 2015 | 339 | 0.030 |
Why?
|
| Genetic Markers | 2 | 2012 | 2634 | 0.030 |
Why?
|
| Adolescent | 6 | 2018 | 85729 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2015 | 544 | 0.030 |
Why?
|
| Reaction Time | 1 | 2018 | 2091 | 0.020 |
Why?
|
| Sweden | 1 | 2014 | 1341 | 0.020 |
Why?
|
| 3' Flanking Region | 1 | 2010 | 15 | 0.020 |
Why?
|
| Greece | 1 | 2011 | 344 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2010 | 31 | 0.020 |
Why?
|
| Anisotropy | 1 | 2014 | 1263 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2018 | 2018 | 0.020 |
Why?
|
| Occipital Lobe | 1 | 2012 | 377 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2012 | 647 | 0.020 |
Why?
|
| Introns | 1 | 2012 | 991 | 0.020 |
Why?
|
| Heterozygote | 1 | 2016 | 2803 | 0.020 |
Why?
|
| Models, Genetic | 2 | 2012 | 3492 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2004 | 12066 | 0.020 |
Why?
|
| Young Adult | 4 | 2018 | 56392 | 0.020 |
Why?
|
| Case-Control Studies | 3 | 2012 | 21733 | 0.020 |
Why?
|
| Synapses | 1 | 2017 | 1728 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2009 | 298 | 0.020 |
Why?
|
| Germany | 1 | 2010 | 862 | 0.020 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2007 | 42 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 1503 | 0.020 |
Why?
|
| Schizophrenic Psychology | 1 | 2013 | 1671 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 2850 | 0.020 |
Why?
|
| Lod Score | 1 | 2006 | 613 | 0.020 |
Why?
|
| Axons | 1 | 2014 | 1685 | 0.020 |
Why?
|
| Phenotype | 2 | 2014 | 16361 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2012 | 1395 | 0.020 |
Why?
|
| Caenorhabditis elegans | 2 | 2004 | 1417 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 35409 | 0.020 |
Why?
|
| Family | 1 | 2016 | 3144 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2012 | 1656 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2739 | 0.010 |
Why?
|
| Memory | 1 | 2014 | 2173 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 464 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2009 | 3585 | 0.010 |
Why?
|
| Attention | 1 | 2012 | 2393 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 853 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2006 | 2419 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2004 | 1574 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2004 | 1202 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2004 | 1063 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 29777 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2012 | 9848 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2004 | 1552 | 0.010 |
Why?
|
| Pedigree | 1 | 2006 | 4643 | 0.010 |
Why?
|
| Exons | 1 | 2004 | 2438 | 0.010 |
Why?
|
| Models, Biological | 1 | 2015 | 9582 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 9648 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 2086 | 0.010 |
Why?
|
| Protein Transport | 1 | 2004 | 1988 | 0.010 |
Why?
|
| Time Factors | 1 | 2019 | 40038 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 3847 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 40545 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2016 | 12209 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 4183 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 5692 | 0.010 |
Why?
|
| Rats | 1 | 2012 | 24250 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 3772 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 1940 | 0.010 |
Why?
|
| RNA Interference | 1 | 2004 | 2890 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 6170 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 4326 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 4803 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 2750 | 0.010 |
Why?
|
| Animals | 3 | 2012 | 168660 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2007 | 23327 | 0.000 |
Why?
|
| Neurons | 1 | 2004 | 9336 | 0.000 |
Why?
|